Literature DB >> 25687429

Fact or fiction? Examining a role for N-methyl-D-aspartate receptor autoantibodies in psychiatric illness.

Matthew S Kayser1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25687429      PMCID： PMC4477517          DOI： 10.1016/j.biopsych.2014.12.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  10 in total

1.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Authors:  C Hammer; B Stepniak; A Schneider; S Papiol; M Tantra; M Begemann; A-L Sirén; L A Pardo; S Sperling; S Mohd Jofrry; A Gurvich; N Jensen; K Ostmeier; F Lühder; C Probst; H Martens; M Gillis; G Saher; F Assogna; G Spalletta; W Stöcker; T F Schulz; K-A Nave; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

2.  Seroprevalence of autoantibodies against brain antigens in health and disease.

Authors:  Liane Dahm; Christoph Ott; Johann Steiner; Beata Stepniak; Bianca Teegen; Sandra Saschenbrecker; Christian Hammer; Kathrin Borowski; Martin Begemann; Sandra Lemke; Kristin Rentzsch; Christian Probst; Henrik Martens; Jürgen Wienands; Gianfranco Spalletta; Karin Weissenborn; Winfried Stöcker; Hannelore Ehrenreich
Journal:  Ann Neurol       Date:  2014-06-23       Impact factor: 10.422

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.

Authors:  Joseph C Masdeu; Ana González-Pinto; Carlos Matute; Sonia Ruiz De Azúa; A Palomino; Jose De Leon; Karen F Berman; Josep Dalmau
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

5.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

6.  Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

Authors:  Johann Steiner; Martin Walter; Wenzel Glanz; Zoltán Sarnyai; Hans-Gert Bernstein; Stefan Vielhaber; Andrea Kästner; Martin Skalej; Wolfgang Jordan; Kolja Schiltz; Christine Klingbeil; Klaus-Peter Wandinger; Bernhard Bogerts; Winfried Stoecker
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

7.  Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.

Authors:  Matthew S Kayser; Maarten J Titulaer; Núria Gresa-Arribas; Josep Dalmau
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

8.  Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.

Authors:  Karrnan Pathmanandavel; Jean Starling; Vera Merheb; Sudarshini Ramanathan; Nese Sinmaz; Russell C Dale; Fabienne Brilot
Journal:  Biol Psychiatry       Date:  2014-07-23       Impact factor: 13.382

9.  Disease-relevant autoantibodies in first episode schizophrenia.

Authors:  Michael S Zandi; Sarosh R Irani; Bethan Lang; Patrick Waters; Peter B Jones; Peter McKenna; Alasdair J Coles; Angela Vincent; Belinda R Lennox
Journal:  J Neurol       Date:  2010-10-26       Impact factor: 4.849

10.  Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.

Authors:  Michael S Zandi; Ross W Paterson; Mark A Ellul; Leslie Jacobson; Adam Al-Diwani; Joanne L Jones; Amanda L Cox; Belinda Lennox; Maria Stamelou; Kailash P Bhatia; Jonathan M Schott; Alasdair J Coles; Dimitri M Kullmann; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-09-22       Impact factor: 10.154
  10 in total
  5 in total

Review 1.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397

2.  Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses.

Authors:  Adam Al-Diwani; Thomas A Pollak; Alexander E Langford; Belinda R Lennox
Journal:  Front Psychiatry       Date:  2017-02-06       Impact factor: 4.157

3.  Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia.

Authors:  Sehba Husain-Krautter; Jihui Lee; Duncan Vos; Juan A Gallego; Anil K Malhotra; Thomas L Rothstein
Journal:  Behav Brain Res       Date:  2022-01-07       Impact factor: 3.352

Review 4.  Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.

Authors:  T A Pollak; K Beck; S R Irani; O D Howes; A S David; P K McGuire
Journal:  Psychopharmacology (Berl)       Date:  2015-12-14       Impact factor: 4.530

5.  Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay.

Authors:  Nan-Chang Chiu; Yi-Jie Lin; Ruu-Fen Tzang; Ying-Syuan Li; Hui-Ju Lin; Subir Das; Caleb G Chen; Chiao-Chicy Chen; Kate Hsu
Journal:  Front Neurol       Date:  2018-08-22       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.